"Ear Nose & Throat Care"

During the past decade, Ear, Nose, and Throat Specialty Care of Minnesota, P.A. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ear, Nose, and Throat Specialty Care of Minnesota, P.A." are "Head and Neck Cancer" (2 trials), "Oral Complications" (1 trials) and "Radiation Toxicity" (1 trials). Many other conditions were trialed in "Ear, Nose, and Throat Specialty Care of Minnesota, P.A." in a lesser frequency.

Most popular intervention types in "Ear, Nose, and Throat Specialty Care of Minnesota, P.A." are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "cevimeline hydrochloride" (1 trials) and "temoporfin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ear, Nose, and Throat Specialty Care of Minnesota, P.A." are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ear, Nose, and Throat Specialty Care of Minnesota, P.A.". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ear, Nose, and Throat Specialty Care of Minnesota, P.A., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ear, Nose, and Throat Specialty Care of Minnesota, P.A., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".